Welcome to our dedicated page for Trupanion SEC filings (Ticker: TRUP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Trupanion, Inc. (NASDAQ: TRUP) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its business as a provider of medical insurance for cats and dogs. These SEC filings cover areas such as financial performance, risk factors, capital structure, governance, and material agreements that shape the company’s operations and its TRUP stock profile.
Key filings for Trupanion include annual reports on Form 10-K, which describe its subscription and other business segments, geographic reach, insurance entities, and risk considerations; and quarterly reports on Form 10-Q, which update investors on revenue from subscription and other business, enrolled pet counts, net income or loss, cash flows, and technology and development spending. Current reports on Form 8-K disclose material events, such as new credit agreements, earnings releases, and board appointments.
For example, Trupanion has used Form 8-K to report entering into a credit agreement with PNC Bank that provides term loan and revolving credit facilities secured by substantially all of the company’s and certain subsidiaries’ assets, and to announce the appointment of a new independent director to its board. Other 8-K filings reference the issuance of press releases detailing quarterly financial results.
Investors can also review Trupanion’s disclosures on non-GAAP financial measures, forward-looking statements, and risk factors, which are discussed in its periodic reports and referenced in earnings-related filings. These documents explain how the company views metrics such as adjusted EBITDA, net acquisition cost, and cash flow, and outline factors that could affect future performance, including claims trends, retention, regulatory constraints, and capital requirements.
On this page, Stock Titan presents Trupanion’s SEC filings alongside AI-powered summaries that highlight the main points of lengthy documents, such as 10-K and 10-Q reports. Users can quickly identify important information on segment performance, debt arrangements, and governance changes, while still having access to the full text of each filing for deeper review.
TRUPANION, INC. Chief Operating Officer John R. Gallagher executed an open-market sale of 430 shares of common stock at $25.47 per share on March 30, 2026, under a pre-established Rule 10b5-1 trading plan. He continues to hold 31,957 shares directly after this transaction.
TRUP submitted a Rule 144 notice reporting planned sales of restricted common stock and two recent dispositions by John Gallagher. The filing lists restricted-stock items dated 05/25/2023 (180 shares) and 02/25/2023 (250 shares) as securities to be sold. It also reports two past sales by John Gallagher: 5,283 shares for $140,080.33 on 02/27/2026 and 430 shares for $13,618.10 on 01/28/2026.
Trupanion Inc disclosure: The Vanguard Group filed an amended Schedule 13G/A reporting beneficial ownership of 0 shares of Common Stock, representing 0% of the class as of the amendment. The filing explains an internal realignment effective January 12, 2026 under SEC Release No. 34-39538 that caused certain Vanguard subsidiaries or business divisions to report disaggregated ownership separately. The form lists Vanguard's address and states no sole or shared voting or dispositive power over Trupanion shares; the amendment is signed on 03/27/2026.
TRUPANION, INC. Chief Revenue Officer Emily Dreyer reported an open-market sale of company stock. On March 4, 2026, she sold 7,792 shares of common stock at an average price of $28.1468 per share. After this transaction, she directly owned 35,627 common shares.
Trupanion, Inc. Chief Financial Officer Fawwad Qureshi reported an open-market sale of 2,837 shares of common stock on February 27, 2026, at a weighted average price of $26.4629 per share. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 19, 2025, and left him with no directly held shares reported after the transaction.
TRUPANION, INC. Chief Operating Officer John R. Gallagher reported an open-market sale of 5,283 shares of common stock on February 27, 2026, at a weighted average price of $26.5153 per share. Following this transaction, he directly owned 32,387 shares.
The sale was executed under a pre-established Rule 10b5-1 trading plan adopted on August 20, 2025, as part of a plan of financial diversification, meaning Gallagher had no discretion over the timing. The weighted average price reflects multiple trades between $26.08 and $26.84 per share.
Trupanion, Inc. CEO Margaret Tooth reported routine equity compensation activity involving restricted stock units (RSUs) and related tax withholding. On February 25, 2026, RSUs converted into 3,266 and 1,250 shares of common stock on a one-for-one basis, reflecting previously granted awards.
To cover income tax obligations from these vestings, the company withheld 1,285 and 491 common shares at $26.70 per share, which the disclosure states does not represent a sale by the CEO. Following these transactions, Margaret Tooth directly owned 164,829 Trupanion common shares.
Trupanion, Inc. Chief Administration Officer Brenna McGibney reported RSU vesting and related share movements. On February 25, 2026, she acquired 646 shares of common stock through the conversion of restricted stock units at $0.00 per share.
To cover income tax withholding on this vesting, a total of 343 common shares were disposed of at $26.70 per share, as disclosed as a tax-withholding disposition rather than an open-market sale. After these transactions, she directly owned 8,453 shares of Trupanion common stock.
TRUPANION, INC. director Darryl Rawlings exercised previously granted restricted stock units, converting them into common shares. On February 25, 2026, 946 RSUs were exercised at a price of $0.00 per unit and converted into 946 shares of common stock on a one-for-one basis. Following this non-cash derivative conversion, Rawlings directly owned 42,232 shares of Trupanion common stock.